Literature DB >> 2469336

Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria.

A Suhrbier1, A A Holder, M F Wiser, J Nicholas, R E Sinden.   

Abstract

The precursor of major merozoite surface antigens (PMMSA) and its proteolytic products are candidates for an asexual blood stage vaccine. Previous authors have shown that PMMSA epitopes are expressed in the liver or exoerythrocytic (EE) stage of malaria. Using Plasmodium berghei, we show that the molecular weight of the liver stage PMMSA is similar to that of the blood stage and that both EE and blood stage proteins are similarly processed. In the EE stage, it was synthesized toward the end of schizogony and appeared first to localize to the rough endoplasmic reticulum and then, as the cytomeres began to form, to the parasite plasmalemma. The EE and blood stage merozoites expressed similar amounts of this antigen as determined by indirect immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469336     DOI: 10.4269/ajtmh.1989.40.351

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.

Authors:  A Suhrbier; L A Winger; E Castellano; R E Sinden
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

3.  Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.

Authors:  Yuko Kawabata; Heiichiro Udono; Kiri Honma; Masakatsu Ueda; Hiroshi Mukae; Jun-Ichi Kadota; Shigeru Kohno; Katsuyuki Yui
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.

Authors:  Feng Qian; Weiqing Pan
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques.

Authors:  Muzamil Mahdi Abdel Hamid; Edmond J Remarque; Ibrahim M El Hassan; Ayman A Hussain; David L Narum; Alan W Thomas; Clemens H M Kocken; Walter R Weiss; Bart W Faber
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

6.  Investigating zoonotic infection barriers to ape Plasmodium parasites using faecal DNA analysis.

Authors:  Dorothy E Loy; Meagan A Rubel; Alexa N Avitto; Weimin Liu; Yingying Li; Gerald H Learn; Alessia Ranciaro; Eric Mbunwe; Charles Fokunang; Alfred K Njamnshi; Paul M Sharp; Sarah A Tishkoff; Beatrice H Hahn
Journal:  Int J Parasitol       Date:  2018-02-21       Impact factor: 3.981

7.  Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells.

Authors:  Karine Kaiser; Nelly Camargo; Stefan H I Kappe
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

8.  Protection of Malian children from clinical malaria is associated with recognition of multiple antigens.

Authors:  Modibo Daou; Bourèma Kouriba; Nicolas Ouédraogo; Issa Diarra; Charles Arama; Yamoussa Keita; Sibiri Sissoko; Boucary Ouologuem; Seydou Arama; Teun Bousema; Ogobara K Doumbo; Robert W Sauerwein; Anja Scholzen
Journal:  Malar J       Date:  2015-02-05       Impact factor: 2.979

9.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

10.  Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.

Authors:  Ashley M Vaughan; Matthew T O'Neill; Alice S Tarun; Nelly Camargo; Thuan M Phuong; Ahmed S I Aly; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2008-12-03       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.